NewsBenzinga누베이션 바이오, 사푸시데닙의 중추적 3상 SIGMA 연구를 위해 6개 유럽 국가에 시험기관 추가 계획 누베이션 바이오, 사푸시데닙의 중추적 3상 SIGMA 연구를 위해 6개 유럽 국가에 시험기관 추가 계획 Benzinga 2026.10.29 12:01 (GMT+0) Open on Benzinga Other news Arthur Hayes: Bullish on ETH, ZEC, NEAR and VVV, Has Built Small- and Mid-Sized Positions Huang's Nvidia Return Odds Rebound to 11% on Kalshi Hackers Spread Crypto-Stealing Trojan via Fake GTA 6 PC Download Links Invesco's Stablecoin Reserve Fund Goes Live on Ethereum 7 Major US Banks Disclose XRP ETF Holdings in SEC Filings, Totaling About $29.4M Anthropic Requires Employees to Set Written Plans 30 Days in Advance to Sell Shares, to Prevent Insider Trading
Anthropic Requires Employees to Set Written Plans 30 Days in Advance to Sell Shares, to Prevent Insider Trading